Clinical Trial Update: Microparticles and the Risk of Re-stenosis Following Balloon Angioplasty in Patients With Peripheral Arterial Disease

View source ↗

Summary

A clinical trial evaluating microparticles and the risk of restenosis after balloon angioplasty in patients with peripheral artery disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Peripheral Vascular Diseases | Status: WITHDRAWN